Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

January 02, 2020 08:14 ET | Source: Amarantus Bioscience Holdings, Inc.

Amarantus Completes Sublicense of ESS, MANF and PhenoGuard to Emerald Organic Products

Emerald gains exclusive worldwide development rights to ESS, MANF and PhenoGuard Amarantus receives Emerald preferred stock valued at a minimum of $66.6 million New York, NY, Jan. 02,...